A Comprehensive Review of the Treatment of Atopic Eczema

被引:59
|
作者
Lee, Ji Hyun [1 ]
Son, Sag Wook [2 ]
Cho, Sang Hyun [1 ]
机构
[1] Catholic Univ Korea, Dept Dermatol, Seoul, South Korea
[2] Korea Univ, Coll Med, Dept Dermatol, 73 Inchon Ro, Seoul 02841, South Korea
关键词
Eczema; atopic dermatitis; atopic eczema; treatment; prevention; epidemiology; TOPICAL CALCINEURIN INHIBITORS; INTERFERON-GAMMA-THERAPY; DOUBLE-BLIND; FLUTICASONE PROPIONATE; STAPHYLOCOCCUS-AUREUS; EPIDERMAL BARRIER; NATURAL-HISTORY; RISK-FACTORS; DERMATITIS; CHILDREN;
D O I
10.4168/aair.2016.8.3.181
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Atopic eczema (AE) is a chronic, inflammatory skin disorder which usually develops in early childhood. In spite of intensive investigations, the causes of AE remain unclear, but are likely to be multifactorial in nature. Environmental factors or genetic-environmental interactions seem to play a key role in disease progression. Among various measures of AE managment, cutaneous hydration, which improves barrier function and relieve itchiness, may be helpful to reduce the need for topical steroid use and therefore should be used as a basic treatment. Avoiding aggravating factors is also a basic treatment of AE. Standard medical treatment with a pharmacologic approach may be necessary if basic treatment fails to control symptoms satisfactorily. Recently, more attention is given to a proactive therapeutic by regular intermittent application of low potency steroids or topical calcineurin inhibitors to prevent new flares. Furthermore, various targeted biologics are being introduced for AE control and are proposed as promising therapies. This paper provides a summary of the recent literature on the manangement of AE and a treatment guideline.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 50 条
  • [11] Economic evidence for the prevention and treatment of atopic eczema: A protocol for a systematic review
    Sach T.H.
    McManus E.
    Mcmonagle C.
    Levell N.
    Systematic Reviews, 5 (1)
  • [12] A Cochrane systematic review of specific allergen immunotherapy for the treatment of atopic eczema
    Tam, H. H.
    Calderon, M. A.
    Manikam, L.
    Nankervis, H.
    Nunez, I. G.
    Williams, H. C.
    Durham, S.
    Boyle, R. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (06) : E54 - E54
  • [13] Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review
    Tam, H. H.
    Calderon, M. A.
    Manikam, L.
    Nankervis, H.
    Nunez, I. G.
    Williams, H. C.
    Durham, S. R.
    Boyle, R. J.
    ALLERGY, 2016, 71 (09) : 1345 - 1356
  • [14] An overview of topical treatment for atopic eczema
    Motswaledi, Mojakgomo
    SA PHARMACEUTICAL JOURNAL, 2012, 79 (06) : 27 - 28
  • [15] UREA IN TOPICAL TREATMENT OF ATOPIC ECZEMA
    HINDSON, TC
    ARCHIVES OF DERMATOLOGY, 1971, 104 (03) : 284 - +
  • [16] Treatment of atopic eczema with oral alitretinoin
    Grahovac, M.
    Molin, S.
    Prinz, J. C.
    Ruzicka, T.
    Wollenberg, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (01) : 217 - 218
  • [17] Obstacles to the delivery of treatment for atopic eczema
    Ho, H. F.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2009, 17 (03): : 127 - 128
  • [18] Atopic hand eczema and treatment strategies
    Andersen, KE
    ACTA DERMATO-VENEREOLOGICA, 2005, : 45 - 48
  • [19] THE TREATMENT OF ATOPIC ECZEMA WITH SYSTEMIC STEROIDS
    SNEDDON, IB
    BRITISH JOURNAL OF DERMATOLOGY, 1960, 72 (01) : 1 - 6
  • [20] TREATMENT OF ECZEMA (ATOPIC DERMATITIS) IN INFANCY
    GLASER, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1948, 137 (06): : 527 - 531